Buy CBRE now: price is sitting near key support (S1 ~164.64; S2 ~162.28) after a sharp pullback, while longer-term trend structure remains bullish (SMA_5 > SMA_20 > SMA_200).
Sentiment backdrop is constructive: hedge funds are increasing buying (+113% QoQ), options positioning is call-leaning, and analysts are uniformly positive with rising targets.
Near-term catalyst: next earnings (QDEC 2025) on 2026-02-12 pre-market; recent quarterly growth suggests upside narrative can persist.
Trend / structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the broader uptrend is intact, but price is currently in a short-term downswing.
Momentum: MACD histogram -0.592 and negatively expanding = bearish momentum still active (pullback not fully “done”).
RSI: RSI_6 27.6 implies an oversold/washed-out condition, favoring a bounce attempt rather than chasing higher.
Levels to watch: Support S1 164.64 (very close to pre-market 164.16) then S2 162.28. Reclaiming the pivot 168.47 would improve the near-term technical tone; resistance zones 172.29 / 174.65.
Pattern-based forward look (similar candlestick analogs): 70% chance of **+3.87%** over the next week, but next-day expectation is slightly negative (~-0.17%).
Volatility: 30D IV 28.68% vs historical vol 22.7% = options are priced with a moderate premium.
Activity: Today’s options volume is low vs typical (today 72 vs 5D avg 107.6 / 10D avg 90.3; and ~25% of 30D avg), so sentiment is positive but not backed by unusually large flow.
OI context: Total OI ~13,243 with calls (8,469) > puts (4,774), consistent with a bullish tilt.
Technical Summary
Sell
0
Buy
12
Positive Catalysts
Earnings catalyst ahead: QDEC 2025 earnings on 2026-02-12 (pre-market).
Strong recent growth: last reported quarter showed double-digit revenue growth and strong EPS acceleration.
Wall Street stance improving: multiple bullish initiations/upgrades and rising price targets (190–192 range).
Hedge fund accumulation: buying increased 113% QoQ, supportive for demand/positioning.
No negative news flow reported in the past week (clean tape).
Neutral/Negative Catalysts
Short-term momentum is still bearish (MACD worsening), so price could still probe 162–165 support before stabilizing.
Gross margin compression (down YoY) can pressure narrative if it persists into the next print.
No recent news catalysts to immediately reverse momentum before earnings (bounce may rely on technicals/market tone).
2025-12-14 Keefe Bruyette: upgraded to Outperform, PT raised to $185 (from $168).
2026-01-08 Keefe Bruyette: reiterated Outperform, PT raised to $192.
Wall Street pros view (pros): positioned for a gradual commercial real estate recovery; CBRE seen as best-in-class services platform to benefit.
Wall Street cons view (cons): execution/margin sensitivity through the cycle (recent gross margin decline is the main measurable flag).
Wall Street analysts forecast CBRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBRE is 186 USD with a low forecast of 175 USD and a high forecast of 192 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast CBRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBRE is 186 USD with a low forecast of 175 USD and a high forecast of 192 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 166.180
Low
175
Averages
186
High
192
Current: 166.180
Low
175
Averages
186
High
192
Keefe Bruyette
Jade Rahmani
Outperform
maintain
$185 -> $192
AI Analysis
2026-01-08
Reason
Keefe Bruyette
Jade Rahmani
Price Target
$185 -> $192
AI Analysis
2026-01-08
maintain
Outperform
Reason
Keefe Bruyette analyst Jade Rahmani raised the firm's price target on CBRE Group to $192 from $185 and keeps an Outperform rating on the shares.
Keefe Bruyette
Keefe Bruyette
Market Perform -> Outperform
upgrade
$168 -> $185
2025-12-14
Reason
Keefe Bruyette
Keefe Bruyette
Price Target
$168 -> $185
2025-12-14
upgrade
Market Perform -> Outperform
Reason
Keefe Bruyette upgraded CBRE Group to Outperform from Market Perform with a price target of $185, up from $168. The firm adjusted ratings in the real estate sector as part of its 2026 outlook. Keefe expects the commercial real estate cycle to enter a "more secure recovery phase with moderate yet still healthy growth" in 2026. This favors commercial real estate services names and "high-quality" commercial mortgage real estate investment trusts, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CBRE
